Literature DB >> 12492589

Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.

Manuel D Carcao1, Victor S Blanchette, Cindy D Wakefield, Derick Stephens, Janet Ellis, Kimberly Matheson, Gregory A Denomme.   

Abstract

Fcgamma receptor-mediated destruction of autoantibody-sensitized platelets is central to the immune pathophysiology of childhood immune thrombocytopenic purpura (ITP). Allelic variants exist among the random population for some Fcgamma receptors. The variants represent single nucleotide polymorphisms, leading to functional differences in the ability to bind immunoglobulin (Ig)G or IgG subclasses. The genotypic frequencies for two Fcgamma receptor single nucleotide polymorphisms, FcgammaRIIa-131 arginine (R) versus histidine (H) and FcgammaRIIIa-158 valine (V) versus phenylalanine (F) were examined in 98 children diagnosed with childhood ITP. The genotype frequencies were compared with those of 130 healthy control subjects. Chi-square analysis was used to determine whether the allelic frequencies of the high-affinity receptor variants were associated with childhood ITP. Both the FcgammaRIIa-131H and the FcgammaRIIIa-158V were significantly over-represented in children with ITP versus the control subjects (P-values 0.03). The same statistical difference was noted with the combined FcgammaRIIa-131H and FcgammaRIIIa-158V allelic gene frequencies. There was no statistical difference between children who later developed chronic ITP compared with children with acute ITP, suggesting that additional factors are responsible for the development of the chronic form of the disease. These observations underscore the importance of Fcgamma receptor-mediated cell clearance in childhood ITP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492589     DOI: 10.1046/j.1365-2141.2003.04033.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Immune thrombocytopenia in children and adults: what's the same, what's different?

Authors:  Harald Schulze; Gerhard Gaedicke
Journal:  Haematologica       Date:  2011-12       Impact factor: 9.941

Review 2.  Genetic studies in pediatric ITP: outlook, feasibility, and requirements.

Authors:  Anke K Bergmann; Rachael F Grace; Ellis J Neufeld
Journal:  Ann Hematol       Date:  2010-03-23       Impact factor: 3.673

3.  Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia.

Authors:  S Audia; K Santegoets; A G Laarhoven; G Vidarsson; O Facy; P Ortega-Deballon; M Samson; N Janikashvili; P Saas; B Bonnotte; T R Radstake
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

4.  Immunoglobulins: current understanding and future directions.

Authors:  S Jolles; S C Jordan; J S Orange; I N van Schaik
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

5.  Fc-dependent mechanisms of action: roles of FcγR and FcRn.

Authors:  T Kuijpers
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

6.  FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.

Authors:  Julien Lejeune; Benoît Piègu; Valérie Gouilleux-Gruart; Marc Ohresser; Hervé Watier; Gilles Thibault
Journal:  MAbs       Date:  2012-10-02       Impact factor: 5.857

7.  Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.

Authors:  Adam M Boruchov; Glenn Heller; Maria-Concetta Veri; Ezio Bonvini; Jeffrey V Ravetch; James W Young
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

8.  Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Annemieke G Laarhoven; Marrie C A Bruin; Barbera Veldhuisen; Sietse Q Nagelkerke; Taco W Kuijpers; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Masja de Haas
Journal:  Blood Adv       Date:  2019-07-09

9.  Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis.

Authors:  Rute B Marques; Mohamed M Thabet; Stefan J White; Jeanine J Houwing-Duistermaat; Aleida M Bakker; Gert-Jan Hendriks; Alexandra Zhernakova; Tom W Huizinga; Annette H van der Helm-van Mil; Rene E Toes
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

10.  DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia.

Authors:  Margarita Pesmatzoglou; Marilena Lourou; George N Goulielmos; Eftichia Stiakaki
Journal:  Clin Dev Immunol       Date:  2012-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.